Compass Pathways Appoints a New CEO
George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?
George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?
Deficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in its tracks
Many researchers are rushing to validate the efficacy of psilocybin microdosing for a variety of ailments, but are these studies reliable?
Mushroom supplements can provide a natural way to boost mood, lower stress, and improve sleep. Here’s what you need to know.
The Netflix documentary ‘How to Change Your Mind’ is great TV even though it fails to provide balanced coverage of psychedelics
People around the world are learning about the mental health benefits of psychedelics. Here are 5 countries where psychedelics are legal.
Michael Pollan’s landmark book is now a streaming miniseries, but is the Netflix psychedelics documentary worth the watch?
Summertime offers many great opportunities to explore nature, and hiking on mushrooms is a wondrous way to enjoy the great outdoors
Psychedelic companies rely on novel patents to boost their value, but many players in the space are chasing the same IP
Microdosing psilocybin mushrooms for depression is becoming mainstream, but current laws still make this treatment extremely risky
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.